Anti-Osteoporosis Therapy and Fracture Healing Market Size, Trends, Latest Insights, Analysis and Forecast 2023-2030 | Amgen Inc, Bioventus, Djo LLC

Global anti osteoporosis therapy and fracture healing market is estimated to grow at a CAGR of 3.0% during the forecast period. A study was conducted to calculate the number of patients with hip fractures who subsequently initiate treatment with anti-osteoporotic medicine. Copenhagen University Hospital, Herlev, conducted a study from June 2019 to May 2020. A total of 627 patients were admitted with a hip or near-hip fracture in the one-year study period. At the time of the hip fracture, 570 patients were 65 years of age or older and 74% were women. Men were slightly younger than women at the time of fracture. At follow-up, 26% of the patients had died. However, the study unveiled that men had a higher death rate than women. Additionally, various initiatives programs, and spending on R&D by regulatory bodies, strengthen the market growth. For instance, in June 2021, a new joint initiative by the International Osteoporosis Foundation and Asia Pacific Orthopaedic Association calls on orthopaedic surgeons to strengthen collaboration with physicians to improve secondary fracture prevention and patient outcomes. The new publication features key messages related to fracture management, post-fracture rehabilitation, fracture healing and national fracture registries. Asian countries are facing the most marked increase in fragility fractures globally, with the number of people at high fracture risk expected to double from 2010-2030.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/anti-osteoporosis-therapy-and-fracture-healing-market

Moreover, according to the International osteoporosis foundation, in 2022, there are 6.2 million Australians over the age of 50 with osteoporosis or osteopenia. That is a 31% increase from 2012. as per the same source, Asian countries will face the most marked increase in fractures globally, with projections suggesting that by 2050, 50% of hip fractures will occur in Asia, the majority of which will happen in China. The number of individuals at high fracture risk in the region is expected to double from 2010- 2030.

Market Coverage

• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Drug Type
o By Route of Administration
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including GlaxoSmithKline, Medtronic Plc, Merck & Co. Inc.,Pfizer, and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anti Osteoporosis Therapy and Fracture Healing Market Report Segment

By Drug Type

• Calcitonin
• Bisphosphonates
o Alendronate (Fosamax)
o Risedronate (Actonel)
o Ibandronate (Boniva)
o Zoledronic acid (Reclast)
• Hormone Replacement Therapy
• Anabolics
• Others (denosumab, and raloxifene)

By Route of Administration

• Oral
• Injectable

By Distribution Channel

• Clinics
• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• E-Commerce

A full report of Anti Osteoporosis Therapy and Fracture Healing Market available @ https://www.omrglobal.com/industry-reports/anti-osteoporosis-therapy-and-fracture-healing-market

Anti Osteoporosis Therapy and Fracture Healing Market Report Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Amgen Inc
• Bioventus
• Djo LLC
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd
• Orthofix US LLC
• OssaTechnics
• Osteo-Pharma BV
• Stryker
• Teva Pharmaceutical Industries Ltd.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Related Report

https://www.somosxbox.com.mx/noticias-urgente/tamano-del-mercado-de-equipos-de-transmision-participacion-crecimiento-investigacion-y-pronostico-2022-2028/124401/

https://ekz-crosstour.ch/news/der-weltweite-markt-fuer-molekulare-point-of-care-diagnostik-soll-bis-2030-56-milliarden-us-dollar-erreichen/141338/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.